Latest news with #ChronicDiseases
CNN
31-07-2025
- Health
- CNN
Questions and expectations swirl as Monarez steps into director's role at CDC
Federal agencies Vaccines Chronic diseases Disability issuesFacebookTweetLink Follow Dr. Susan Monarez will be sworn in as director of the US Centers for Disease Control and Prevention on Thursday, and she's taking the reins at a perilous time for the agency. The CDC has lost nearly a quarter of its staff since January, thanks to massive workforce cuts at federal health agencies. The Trump administration's proposed budget for the fiscal year 2026 would slash the agency's funding by more than half. And under a proposed reorganization, the agency stands to lose more of its programs: Some are set to be moved to a new Administration for a Healthy America while others, such as the National Center for Chronic Disease and Health Promotion, would be eliminated altogether. All this is playing out as US Health and Human Services Secretary Robert F. Kennedy Jr., who has long promoted misinformation about vaccines, has moved to undermine longstanding federal policies and processes that support vaccination in the United States. Kennedy has also throttled communications coming out of federal health agencies, including the CDC, all but silencing its scientists amid the worst measles outbreak in the US in three decades. Many at the agency and in the wider public health world are wondering whether Monarez will prove to be a savior or a sycophant. Morale among agency staff is bleak, according to one CDC official who spoke on the condition that they not be named for fear of reprisals. Staffers are feeling unsure about what Monarez's confirmation means, the official said. Many see her as a good scientist and someone with experience in leadership positions at federal agencies. But they also wonder whether she'll be constrained by Kennedy, the official said. Monarez's tenure in government spans Republican and Democratic administrations. Before coming to the CDC in January, she was deputy director for the Advance Research Projects Agency for Health, or ARPA-H, and was founding director of the Center for Innovation at the Health Resources and Services Administration. She held other leadership positions at the Department of Homeland Security and the Biomedical Advanced Research and Development Authority. In her confirmation hearing, Monarez described herself as the daughter of a dairy farmer from rural Wisconsin who attended state schools and paid her own way through college, eventually earning a Ph.D. in microbiology and immunology. She said that her research was focused on two diseases, African sleeping sickness and toxoplasmosis, and that she was drawn to public health because treatments for those diseases remain limited but public health interventions have reduced the impact of the diseases. Under questioning by senators, Monarez seemed to distance herself from Kennedy on two issues: vaccines and fluoride. In response to questions from Sen. Bernie Sanders, an independent from Vermont, about the US ending its support for the Global Alliance for Vaccines and Immunization, Monarez said, 'I think vaccines save lives. I think that we need to continue to support the promotion and utilization of vaccines.' When Sanders asked whether she agrees that there is no scientific proven link between vaccines and autism, Monarez said, 'I have not seen a causal link between vaccines and autism.' Regarding fluoride, Monarez told Sen. Angela Alsobrooks that she considered it 'an important component to oral health. … The direct application can be very valuable.' Alsobrooks asked about fluoridation of public drinking water, including in Monarez's own town. 'They have fluoridation there. Is it safe for families, the water in Potomac, Maryland?' 'I believe the water in Potomac, Maryland, is safe,' Monarez answered. One staffer who worked under Monarez at ARPA-H described her as a quiet presence. She wasn't the type of manager who is an active presence on Slack or email, they said. 'We all respected her. She's been in government a long time,' said the staffer, who spoke on the condition that they not be named for fear of retaliation. Dr. Jennifer Nuzzo, who directs the Pandemic Center at Brown University's School of Public Health, has known Monarez for at least a decade. 'She's a lifelong government scientist who has risen through the ranks to become a very senior leader,' Nuzzo said. 'She's loyal to serving the American people.' They worked together when Monarez was detailed to the White House, where she worked on the US National Action Plan for Combating Antibiotic-Resistant Bacteria. 'She got into the nitty-gritty of a complex policy issue, but she was also able to bring together a really diverse set of stakeholders to provide input into that strategy,' Nuzzo said. 'I think that's a great example of what Susan does.' Monarez has said she has three priorities for the CDC. First, she said, she wants to improve trust in the agency and its recommendations. Next, she will focus on strengthening public health infrastructure by investing in tools to prevent, detect and respond to threats in near real-time. She pledged to collaborate with state and local public health departments to build a nationwide public health network. Finally, she said, she will work to create rapid, evidence-based responses to public health emergencies, with timely communication that is consistent and grounded in facts. While these are worthy goals, Nuzzo said, her biggest worry is whether Monarez will be able to act independently, without political interference. 'You can't run an organization as important and large as the CDC if you need to get permission for everything that needs to be done,' Nuzzo added. Dr. Richard Besser, a former acting director of the CDC, said in a statement that he looked forward to meeting Monarez to better understand her plans to lead the agency. Besser is now president and CEO of the Robert Wood Johnson Foundation. 'Dr. Monarez must not only lead the CDC – she must fight for it. Our nation's entire public health system depends on CDC having the tools it needs to respond to pandemics, reduce chronic disease, and address health inequities that continue to leave too many communities behind. That starts with a director willing to speak the truth, defend science, and stand up for the health of every American,' Besser said.
Yahoo
29-07-2025
- Business
- Yahoo
Medical Gas Market Forecast and Company Analysis Report 2025-2033 Featuring Air Liquide, Linde, Atlas Copco, Inox-Air, Taiyo Nippon Sanso, Matheson Tri-Gas, Horiba, Sol
The Global Medical Gas Market is projected to grow from US$ 14.41 billion in 2024 to US$ 28.61 billion by 2033, with a CAGR of 7.92%. Key drivers include a shift toward home healthcare and telemedicine, rising chronic diseases, and advancements in medical technology. The Asia-Pacific region is expected to see the highest growth due to expanding healthcare sectors. The market faces challenges like stringent regulations and supply chain disruptions. High demand for portable solutions, growing telemedicine, and numerous chronic conditions are shaping the industry. Key players include Air Liquide, Linde PLC, and Atlas Copco Group. Medical Gas Market Dublin, July 29, 2025 (GLOBE NEWSWIRE) -- The "Medical Gas Market Share Analysis and Size - Growth Trends and Forecast Report 2025-2033" report has been added to Global Medical Gas Market is expected to reach US$ 28.61 billion by 2033 from US$ 14.41 billion in 2024, with a CAGR of 7.92% from 2025 to 2033. Some of the key reasons driving the market are the growing tendency toward home healthcare and telemedicine, the prevalence of chronic illnesses including respiratory and cardiovascular diseases (CVDs), and many developments in medical technology. The aging population, rising rates of chronic respiratory conditions, and improvements in healthcare infrastructure are all contributing to the substantial expansion of the worldwide medical gas market. Medical gases, such as carbon dioxide, nitrous oxide, and oxygen, are necessary for a number of therapeutic and diagnostic uses in ambulatory surgery centers, home healthcare settings, and hospitals. The need for portable medical gas solutions, such oxygen concentrators, has increased due to the growing demand for home healthcare services. Due to growing healthcare sectors and government expenditures in medical infrastructure, the Asia-Pacific region is expected to develop at the highest rate, while North America already has a significant market share. The availability and distribution of medical gases may be impacted by supply chain interruptions and strict regulatory restrictions, which provide difficulties for the need for medicinal gases is also being fueled by the increasing incidence of asthma. The Australian Institute of Health and Welfare (AIHW) estimates that in 2023, asthma accounted for 35% of the entire burden related to all respiratory disorders and 2.5% of the overall illness burden. Nitrous oxide, carbon dioxide, nitrogen, oxygen, and medical air are some of the most often utilized medical gases in of the leading companies, Air Liquide Healthcare, provides medicinal gases to 20,000 hospitals and new healthcare facilities, and assists over 2 million people in managing chronic illnesses. Medical gases including heliox, oxygen, and lung gas mixes are widely employed in the diagnosis and treatment of certain respiratory the need for portable medical gases, such as oxygen concentrators, is rising as more people choose home-based healthcare. In order to ensure that chronic patients receive the oxygen therapy they require at home, this change places an emphasis on convenience and continuity of care. Home healthcare has become increasingly popular in recent years and is predicted to continue to grow. Many medical illnesses may now be successfully treated at home, including those that require ventilator assistance, mixed gas therapies, and long-term oxygen therapy. Additionally, it is anticipated that rising home healthcare reimbursement would support market expansion throughout the projection period. The Firesafe Cannula Valve, for example, was formally covered by Iowa Medicaid in November 2023 and was given the HCPCS number E0700 for reimbursement. In the event that the oxygen tubing downstream burns, this novel mechanism functions as a thermal fuse and instantly stops the oxygen supply. Thermal fuses must be installed in all home oxygen systems in the United Kingdom. Interestingly, the US has a 20-fold greater risk of death from oxygen-related flames than England, where installing firebreaks has been required since Drivers for the Medical Gas Market Numerous Medical Technology AdvancementsLaparoscopy and endoscopy are examples of minimally invasive (MI) surgical techniques that have been made possible by technological breakthroughs. Surgeons can execute treatments with fewer incisions, quicker patient recovery, and less tissue stress when medical gases like carbon dioxide are utilized to provide a clean operating field. Furthermore, more specialized and individualized treatment for respiratory problems is now possible because to developments in respiratory therapy equipment. The World Health Organization reports that asthma and other chronic respiratory diseases (CRDs) are on the rise worldwide, with 3.2 million deaths from COPD and 262 million cases of asthma in 2019. Advanced oxygen treatment equipment, such as portable oxygen delivery systems and oxygen concentrators, are used to supply medical gases like oxygen. Additionally, a number of developments in dermatology and cryosurgery have increased the use of medicinal gases, such as liquid nitrogen, to freeze and remove sick or aberrant tissue. The market is being driven by the regulated and focused treatment that cryotherapy equipment provides, which minimizes harm to nearby healthy Preference for Telemedicine and Home HealthcareMedical gases, such as oxygen, are frequently given to patients in their homes as part of home healthcare. To control their symptoms and enhance their quality of life, patients with long-term respiratory diseases like COPD need oxygen treatment. Medical oxygen gases are in greater demand as a result of the shift toward home healthcare, which enables patients to obtain oxygen therapy without the need for extended hospital stays. Furthermore, nebulization, pain relief, and respiratory therapies are only a few of the uses for medical gases that go beyond oxygen therapy. As a result of this trend, fewer extended hospital stays are required, which raises the requirement for medical as cardiovascular disorders are thought to cause 17.9 million deaths worldwide each year, medicinal gases - such as oxygen - are essential for treating associated ailments, which raises the need for at-home therapies. The need for medical gases is further increased by the growth of telemedicine and home healthcare, which enables patients to receive a greater variety of medical gas treatments in the convenience of their own Rates of Chronic Conditions, Including Heart and Respiratory ConditionsMedical gases like oxygen are necessary for respiratory support because to the rising prevalence of respiratory conditions such asthma, interstitial lung disorders, and chronic obstructive pulmonary disease (COPD). Chronic respiratory disorders (CRDs), such as asthma, interstitial lung diseases, and chronic obstructive pulmonary disease (COPD), are on the rise, according to the World Health Organization (WHO). According to the Global Asthma Report, asthma affects an estimated 262 million people globally, and COPD alone was responsible for almost 3.2 million deaths in treatment is necessary for patients who have trouble breathing in order to keep their blood oxygen levels sufficient and to relieve their symptoms. Furthermore, medicinal gases are frequently needed for diagnostic and therapeutic purposes in cardiovascular illnesses, such as heart failure, coronary artery disease, and hypertension. In order to ensure patient comfort and stability during cardiovascular procedures, nitrous oxide is used as an anesthetic agent. Additionally, medicinal gases are essential for palliative care for individuals with chronic illnesses that have in the Medical Gas Market Stringent Regulatory ComplianceBecause medical gases are essential to patient care and safety, the market is subject to strict regulatory compliance. To guarantee that medical gases fulfill therapeutic needs, regulatory agencies impose stringent criteria for purity, labeling, packing, and transportation. Operational complexity can be further increased by the constant monitoring, certification procedures, and thorough paperwork that are frequently required to comply with these rules. To maintain compliance, manufacturers must spend more on qualified staff and sophisticated quality control systems, which raises prices. Furthermore, managing disparate regional restrictions might make international distribution plans more difficult. Although these regulations guarantee patient safety and product dependability, they also place a financial and logistical strain on manufacturers, particularly newly established smaller Production and Storage CostsComplex infrastructure and procedures are needed to produce and store medicinal gases, which raises supply chain costs. To guarantee purity and safety, the gases need to be produced under exacting circumstances, which calls for cutting-edge technology and strict adherence to regulations. Energy-intensive systems are needed for compression and liquefaction, and storage facilities need to be built to withstand temperature changes, pollution, and leakage. Specialized, frequently temperature-controlled containers that adhere to stringent rules are also necessary for the transportation of these gases. Long-term costs are further increased by continuing storage system monitoring and maintenance. These elements work together to make medical gases far more expensive to produce, handle, and distribute than many other medical supplies, which puts a strain on both healthcare providers and suppliers. Key Players Analyzed: Overview, Key Persons, Recent Development & Strategies, Revenue Analysis Air Liquide Linde Plc Atlas Copco Group Inox-Air Products Inc. Taiyo Nippon Sanso Corporation Matheson Tri-Gas, Inc. Horiba Group Sol India Private Limited Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $14.41 Billion Forecasted Market Value (USD) by 2033 $28.61 Billion Compound Annual Growth Rate 7.9% Regions Covered Global Key Topics Covered: 1. Introduction2. Research Methodology2.1 Data Source2.1.1 Primary Sources2.1.2 Secondary Sources2.2 Research Approach2.2.1 Top-Down Approach2.2.2 Bottom-Up Approach2.3 Forecast Projection Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Global Medical Gas Market5.1 Historical Market Trends5.2 Market Forecast6. Medical Gas Market Share Analysis6.1 By Product6.2 By Application6.3 By End Use6.4 By Countries7. Product7.1 Pure Gases7.2 Gas Mixtures8. Application8.1 Therapeutics8.2 Diagnostics8.3 Others9. End Use9.1 Hospitals9.2 Pharmaceutical & Biotechnology Companies9.3 Ambulatory Surgical Centers9.4 Diagnostic & Research Laboratories9.5 Academic & Research Institutes9.6 Home Healthcare10. Countries10.1 North America10.1.1 United States10.1.2 Canada10.2 Europe10.2.1 France10.2.2 Germany10.2.3 Italy10.2.4 Spain10.2.5 United Kingdom10.2.6 Belgium10.2.7 Netherlands10.2.8 Turkey10.3 Asia-Pacific10.3.1 China10.3.2 Japan10.3.3 India10.3.4 South Korea10.3.5 Thailand10.3.6 Malaysia10.3.7 Indonesia10.3.8 Australia10.3.9 New Zealand10.4 Latin America10.4.1 Brazil10.4.2 Mexico10.4.3 Argentina10.5 Middle East & Africa10.5.1 Saudi Arabia10.5.2 UAE10.5.3 South Africa11. Porter's Five Forces Analysis11.1 Bargaining Power of Buyers11.2 Bargaining Power of Suppliers11.3 Degree of Rivalry11.4 Threat of New Entrants11.5 Threat of Substitutes12. SWOT Analysis12.1 Strength12.2 Weakness12.3 Opportunity12.4 Threat13. Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Medical Gas Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
CNN
18-07-2025
- Health
- CNN
High-fructose corn syrup versus cane sugar
Food & health Donald Trump Federal agencies Chronic diseasesFacebookTweetLink Follow President Donald Trump announced this week that the Coca-Cola Company has agreed to his requests for the brand to use 'REAL' cane sugar in its US products instead of high-fructose corn syrup. The company hasn't confirmed the swap, but high-fructose corn syrup has been one of many products targeted by US Health and Human Services Secretary Robert F. Kennedy, Jr. in recent months. Kennedy called the common, cheap sweetener a 'formula for making you obese and diabetic' in a September episode of Dr. Jordan Peterson's podcast. Kennedy and the 'Make America Healthy Again' movement he leads have been lobbying the food and beverage industry to remove several ingredients from product formulations, including artificial food dyes and seed oils. While Coca-Cola is made with high-fructose corn syrup in the United States, its Mexican counterpart is made with cane sugar, a significant export of the country. The company did not confirm Trump's announcement and said it is unable to provide further comment at this time due to its upcoming earnings. Coca-Cola did issue a statement for a Thursday report, saying that 'more details on new innovative offerings within our Coca-Cola product range will be shared soon.' Is cane sugar soda better for you? Sugar-filled soda isn't good for you regardless of whatever sugar is used to sweeten it, according to health experts. 'Excess consumption of sugar from any source harms health,' said Eva Greenthal, senior policy scientist at the Center for Science in the Public Interest, a nonprofit consumer advocacy group, via email. 'What makes soda unhealthy is that it's liquid sugar, providing empty calories with no nutritional benefits. Swapping one type of sugar for another does nothing to make soda healthier.' 'To make the US food supply healthier, the Trump administration should focus on less sugar, not different sugar,' added Greenthal, noting that CSPI and the New York City Department of Health and Mental Hygiene lobbied the US Food and Drug Administration to set added sugar reduction targets for the US food supply, 'similar to FDA's existing sodium reduction targets for industry.' Greenthal urged the administration to implement this policy, while veteran nutrition researcher Dr. Walter C. Willett said there's even more to be done. 'If we are serious about reducing the adverse effects of sugar-sweetened soda, there are many steps we can take, including warning labels on these beverages, limiting sales in schools and other public places, and taxing, then using these taxes to support health and nutrition programs for children,' said Willett, a professor of epidemiology and nutrition at the Harvard T. H. Chan School of Public Health, via email. The corn refining industry opposes the possible swap, denying any nutritional benefit. 'Replacing high fructose corn syrup with cane sugar doesn't make sense,' said John Bode, president and CEO of the Corn Refiners Association, a trade association representing the corn refining market in the US, in a statement. 'President Trump stands for American manufacturing jobs, American farmers, and reducing the trade deficit. Replacing high fructose corn syrup with cane sugar would cost thousands of American food manufacturing jobs, depress farm income, and boost imports of foreign sugar, all with no nutritional benefit.' Cane sugar is produced from sugarcane and is sucrose, a type of sugar naturally comprised of two simple sugars, glucose and fructose, in equal measure. Fructose is commonly called 'fruit sugar' since it naturally occurs in fruits and berries, according to the FDA. High-fructose corn syrup, on the other hand, is made from processed corn starch. Starch is a chain of glucose molecules joined together, according to the FDA. 'When corn starch is broken down into individual glucose molecules, the end product is corn syrup, which is essentially 100% glucose.' To turn that product into high-fructose corn syrup, enzymes are added to convert some of the glucose to fructose. Different formulations of high-fructose corn syrup contain varying amounts of fructose, but the most common forms carry either 42% or 55% fructose, while the rest is glucose and water, according to the FDA. The 42% formulation is often used in processed foods including cereals and baked goods, while the 55% version is primarily used in sodas. Our food supply didn't always include high-fructose corn syrup. Sucrose from sugarcane and sugar beets was the primary sweetener globally until 1957, according to Britannica. That's when said enzymes allowed a turning point in the sweetener industry burdened by the rising costs of sugar; sugar shortages and rations during World War II and the Cuban Revolution; and technological advances in sweetener production in Japan. Consumption of the cheap sweetener in the US began spiking in the 1970s, coinciding with government subsidies for corn farmers. Coca-Cola started using it in the early 1980s to lower costs except in Mexico. The new sweetener was also more stable than sugar, which helps increase product shelf life, according to Sue-Ellen Anderson-Haynes, a registered dietitian nutritionist, certified diabetes educator and owner of 360Girls&Women. Most studies have supported the idea that 'from a nutritional standpoint, there's no difference between high-fructose corn syrup and sucrose,' said Dr. Marion Nestle, the Paulette Goddard Professor of Nutrition, Food Studies, and Public Health, Emerita, at New York University. 'They have the same number of calories,' Nestle said. 'They taste the same.' And there's been a long-held idea that the body doesn't know the difference between the two. However, some recent research challenges this long-held conclusion, according to Anderson-Haynes, a spokesperson for the Academy of Nutrition and Dietetics. 'In terms of how the body metabolizes it, it's a little different than straight sugar,' she said. Consumption of high-fructose corn syrup has been more associated with weight gain, obesity and dyslipidemia, abnormal levels of lipids, or fats, in the blood, Anderson-Haynes added. But it's also true that despite a decline in intake over the past 26 years, according to Britannica, rates of diabetes and obesity have continued to climb. Also, some studies report that 'fatty liver or inflammation in the liver overall really increased with subjects who consume high-fructose corn syrup versus subjects who consume sucrose,' she said. Another study found high-fructose corn syrup is linked to higher levels of C-reactive protein, a substance the liver produces in response to inflammation from various causes or sources. Scientists have also discovered links between consumption and insulin resistance, Anderson-Haynes said. That's a condition in which your muscle, fat and liver cells don't properly respond to insulin, which helps sugar enter your cells to be used for energy. Insulin resistance can lead to high blood sugar and type 2 diabetes. Recent research also found babies who consumed formula sweetened with corn syrup solids had higher blood sugar and a higher risk of obesity by age 4 than those who drank lactose-based formula or breastmilk. Most corn grown in the United States is genetically modified and nearly half is sprayed with glyphosate, a commonly used herbicide that's also another target of the MAHA movement. Glyphosate has most conclusively been linked to cancer, and some researchers are investigating potential connections to infertility and insulin resistance, Anderson-Haynes said. 'Evidence shows that GMO corn is perfectly safe to eat,' Greenthal said. 'But even if you're worried about the safety of GMOs, by the time an ear of corn becomes a soft drink, there's no genetic material left from the corn that made the HFCS.' But really, herbicides should be the least of your worries when it comes to sugar, she said. 'A much more pressing concern is how the liquid sugar will affect your teeth and provide empty calories that can cause weight gain and increase your risk of type 2 diabetes and heart disease.' The healthiest diet is one rich in whole foods, including fruits and vegetables, Anderson-Haynes said. She recommends avoiding added sugar but does think that if you're going to eat it, natural sugar is slightly better than high-fructose corn syrup. People should limit sugar intake to less than 25 grams, or about 6 teaspoons, per day, according to the World Health Organization and other institutions. That's about as much in 2 ½ chocolate chip cookies, 16 ounces of fruit punch or 1 ½ tablespoons of honey — or just a bit over half of a 12-ounce can of Coca-Cola. If you're having trouble kicking a soda habit, consider trying sparkling water with lemon and lime juice and ginger, Anderson-Haynes suggested. Kombucha without added sugar may also sate cravings. Sign up for CNN's Eat, But Better: Mediterranean Style. Our eight-part guide shows you a delicious expert-backed eating lifestyle that will boost your health for life.
CNN
18-07-2025
- Health
- CNN
High-fructose corn syrup versus cane sugar
Food & health Donald Trump Federal agencies Chronic diseasesFacebookTweetLink Follow President Donald Trump announced this week that the Coca-Cola Company has agreed to his requests for the brand to use 'REAL' cane sugar in its US products instead of high-fructose corn syrup. The company hasn't confirmed the swap, but high-fructose corn syrup has been one of many products targeted by US Health and Human Services Secretary Robert F. Kennedy, Jr. in recent months. Kennedy called the common, cheap sweetener a 'formula for making you obese and diabetic' in a September episode of Dr. Jordan Peterson's podcast. Kennedy and the 'Make America Healthy Again' movement he leads have been lobbying the food and beverage industry to remove several ingredients from product formulations, including artificial food dyes and seed oils. While Coca-Cola is made with high-fructose corn syrup in the United States, its Mexican counterpart is made with cane sugar, a significant export of the country. The company did not confirm Trump's announcement and said it is unable to provide further comment at this time due to its upcoming earnings. Coca-Cola did issue a statement for a Thursday report, saying that 'more details on new innovative offerings within our Coca-Cola product range will be shared soon.' Is cane sugar soda better for you? Sugar-filled soda isn't good for you regardless of whatever sugar is used to sweeten it, according to health experts. 'Excess consumption of sugar from any source harms health,' said Eva Greenthal, senior policy scientist at the Center for Science in the Public Interest, a nonprofit consumer advocacy group, via email. 'What makes soda unhealthy is that it's liquid sugar, providing empty calories with no nutritional benefits. Swapping one type of sugar for another does nothing to make soda healthier.' 'To make the US food supply healthier, the Trump administration should focus on less sugar, not different sugar,' added Greenthal, noting that CSPI and the New York City Department of Health and Mental Hygiene lobbied the US Food and Drug Administration to set added sugar reduction targets for the US food supply, 'similar to FDA's existing sodium reduction targets for industry.' Greenthal urged the administration to implement this policy, while veteran nutrition researcher Dr. Walter C. Willett said there's even more to be done. 'If we are serious about reducing the adverse effects of sugar-sweetened soda, there are many steps we can take, including warning labels on these beverages, limiting sales in schools and other public places, and taxing, then using these taxes to support health and nutrition programs for children,' said Willett, a professor of epidemiology and nutrition at the Harvard T. H. Chan School of Public Health, via email. The corn refining industry opposes the possible swap, denying any nutritional benefit. 'Replacing high fructose corn syrup with cane sugar doesn't make sense,' said John Bode, president and CEO of the Corn Refiners Association, a trade association representing the corn refining market in the US, in a statement. 'President Trump stands for American manufacturing jobs, American farmers, and reducing the trade deficit. Replacing high fructose corn syrup with cane sugar would cost thousands of American food manufacturing jobs, depress farm income, and boost imports of foreign sugar, all with no nutritional benefit.' Cane sugar is produced from sugarcane and is sucrose, a type of sugar naturally comprised of two simple sugars, glucose and fructose, in equal measure. Fructose is commonly called 'fruit sugar' since it naturally occurs in fruits and berries, according to the FDA. High-fructose corn syrup, on the other hand, is made from processed corn starch. Starch is a chain of glucose molecules joined together, according to the FDA. 'When corn starch is broken down into individual glucose molecules, the end product is corn syrup, which is essentially 100% glucose.' To turn that product into high-fructose corn syrup, enzymes are added to convert some of the glucose to fructose. Different formulations of high-fructose corn syrup contain varying amounts of fructose, but the most common forms carry either 42% or 55% fructose, while the rest is glucose and water, according to the FDA. The 42% formulation is often used in processed foods including cereals and baked goods, while the 55% version is primarily used in sodas. Our food supply didn't always include high-fructose corn syrup. Sucrose from sugarcane and sugar beets was the primary sweetener globally until 1957, according to Britannica. That's when said enzymes allowed a turning point in the sweetener industry burdened by the rising costs of sugar; sugar shortages and rations during World War II and the Cuban Revolution; and technological advances in sweetener production in Japan. Consumption of the cheap sweetener in the US began spiking in the 1970s, coinciding with government subsidies for corn farmers. Coca-Cola started using it in the early 1980s to lower costs except in Mexico. The new sweetener was also more stable than sugar, which helps increase product shelf life, according to Sue-Ellen Anderson-Haynes, a registered dietitian nutritionist, certified diabetes educator and owner of 360Girls&Women. Most studies have supported the idea that 'from a nutritional standpoint, there's no difference between high-fructose corn syrup and sucrose,' said Dr. Marion Nestle, the Paulette Goddard Professor of Nutrition, Food Studies, and Public Health, Emerita, at New York University. 'They have the same number of calories,' Nestle said. 'They taste the same.' And there's been a long-held idea that the body doesn't know the difference between the two. However, some recent research challenges this long-held conclusion, according to Anderson-Haynes, a spokesperson for the Academy of Nutrition and Dietetics. 'In terms of how the body metabolizes it, it's a little different than straight sugar,' she said. Consumption of high-fructose corn syrup has been more associated with weight gain, obesity and dyslipidemia, abnormal levels of lipids, or fats, in the blood, Anderson-Haynes added. But it's also true that despite a decline in intake over the past 26 years, according to Britannica, rates of diabetes and obesity have continued to climb. Also, some studies report that 'fatty liver or inflammation in the liver overall really increased with subjects who consume high-fructose corn syrup versus subjects who consume sucrose,' she said. Another study found high-fructose corn syrup is linked to higher levels of C-reactive protein, a substance the liver produces in response to inflammation from various causes or sources. Scientists have also discovered links between consumption and insulin resistance, Anderson-Haynes said. That's a condition in which your muscle, fat and liver cells don't properly respond to insulin, which helps sugar enter your cells to be used for energy. Insulin resistance can lead to high blood sugar and type 2 diabetes. Recent research also found babies who consumed formula sweetened with corn syrup solids had higher blood sugar and a higher risk of obesity by age 4 than those who drank lactose-based formula or breastmilk. Most corn grown in the United States is genetically modified and nearly half is sprayed with glyphosate, a commonly used herbicide that's also another target of the MAHA movement. Glyphosate has most conclusively been linked to cancer, and some researchers are investigating potential connections to infertility and insulin resistance, Anderson-Haynes said. 'Evidence shows that GMO corn is perfectly safe to eat,' Greenthal said. 'But even if you're worried about the safety of GMOs, by the time an ear of corn becomes a soft drink, there's no genetic material left from the corn that made the HFCS.' But really, herbicides should be the least of your worries when it comes to sugar, she said. 'A much more pressing concern is how the liquid sugar will affect your teeth and provide empty calories that can cause weight gain and increase your risk of type 2 diabetes and heart disease.' The healthiest diet is one rich in whole foods, including fruits and vegetables, Anderson-Haynes said. She recommends avoiding added sugar but does think that if you're going to eat it, natural sugar is slightly better than high-fructose corn syrup. People should limit sugar intake to less than 25 grams, or about 6 teaspoons, per day, according to the World Health Organization and other institutions. That's about as much in 2 ½ chocolate chip cookies, 16 ounces of fruit punch or 1 ½ tablespoons of honey — or just a bit over half of a 12-ounce can of Coca-Cola. If you're having trouble kicking a soda habit, consider trying sparkling water with lemon and lime juice and ginger, Anderson-Haynes suggested. Kombucha without added sugar may also sate cravings. Sign up for CNN's Eat, But Better: Mediterranean Style. Our eight-part guide shows you a delicious expert-backed eating lifestyle that will boost your health for life.
Globe and Mail
12-07-2025
- Business
- Globe and Mail
Global Enteral Nutrition Market Revenue to Reach $30.96 Billion by 2030: APAC Surge, Oncology Demand, and Tube Feeding Innovation Fuel Growth-Focus Report Store
"Global Enteral Nutrition Market Research Report by Arizton" Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025–2030. Customize this Report. According to a recent research by Focus Reports, the global enteral nutrition market is projected to grow from USD 20.88 billion in 2024 to USD 30.96 billion by 2030, registering a CAGR of 6.78% during the forecast period. Looking for More Information? Click: Report Scope: Market Size (2030): USD 30.96 Billion Market Size (2024): USD 20.88 Billion CAGR (2024-2030): 6.78% Historic Year:2021-2023 Base Year: 2024 Forecast Year: 2025-2030 Largest Region (2024): Asia Pacific Market Segmentation: Feeding Method, Patient Group, Indication, End-User, and Geography Geographic Analysis: North America, Europe, APAC, Latin America, and the Middle East & Africa The global enteral nutrition market is evolving rapidly, driven by the development of more advanced, unique, and organic formulas, rising developments in enteral nutrition (EN) deliveries, and rising coverage and reimbursement in developed markets. The market is growing at a steady pace, and this trend is likely to continue during the forecast period due to the increasing prevalence of various chronic diseases, the rising elderly population, the increasing incidence of preterm births, and the growing incidence of malnutrition in pregnant women. Innovation in Enteral Nutrition: Safer, Smarter, and More Personalized Delivery Enteral nutrition is undergoing a technological transformation, particularly in tube feeding methods where safety and efficiency are critical. One major advancement is the adoption of closed system feeding, which minimizes exposure to contaminants, thereby reducing infection risk and improving medication administration accuracy. These systems are particularly beneficial for patients with multiple health issues, helping prevent dosing errors and accidental disconnections. Additionally, innovations like Hoist Medical's ENFit Connector further enhance safety by reducing the risk of misconnections between medical devices, supporting greater customization in enteral nutrition therapies and unlocking new revenue opportunities in the healthcare sector. Rising Demand for Enteral Nutrition Signals Market Expansion Opportunities The artificial nutrition landscape is evolving rapidly, driven by a surge in chronic diseases, malnutrition, and dysphagia-related cases creating a noticeable shift in clinical practice and patient preference. There has been a clear move toward enteral nutrition particularly tube feeding as the preferred method when the gastrointestinal tract is functional. Medical consensus strongly supports this approach, citing its physiological benefits, ease of administration, and fewer complications compared to parenteral nutrition. A 2023 report from the National Library of Medicine reinforces this trend, highlighting the preference for enteral feeding due to reduced risks of infection and blood clots, along with overall ease of care. Continuous improvements in tube feeding systems focused on safety, accessibility, and application versatility are expanding the definition of a 'functioning gut,' enabling more patients to benefit from enteral support than ever before. Recent Enteral Nutrition Market News In March 2025, Nutrisens Group, one of the emerging companies in clinical nutrition, aims to expand its presence in Latin America with the acquisition of Brazilian Prediet Medical Nutrition, which manufactures oral and enteral nutrition products in a range of forms, including powder, liquid, and tube feeding. This acquisition will strengthen Nutrisens' portfolio as well as regional market penetration. In 2024, Danone, one of the leading market players in the enteral nutrition market, acquired Functional Formularies, a leading whole food tube feeding business in the US. This acquisition is strengthening Danone's Medical Nutrition portfolio by further expanding its tube feeding (enteral nutrition) portfolio. Oncology Segment Dominates Enteral Nutrition Market Amid Rising Cancer Burden The oncology segment leads the global enteral nutrition market, driven by the escalating burden of cancer and its strong correlation with malnutrition. As cancer cases continue to rise globally, so does the need for targeted nutritional support. The Nutrition Journal (2024) highlights that a significant share of cancer patients are at high risk of severe malnutrition a concern echoed by the Oncotarget Journal (2022), which reported that one in three cancer patients in European hospitals are malnourished and often rely on nutritional therapy. Further reinforcing this trend, The World Health Organization's 2024 report, global cancer cases are projected to rise dramatically by 2050, underscoring the urgency of supportive care strategies. Malnutrition among cancer patients is frequently driven by tumor-related complications and the side effects of aggressive treatments. As a result, enteral nutrition has become a critical component of comprehensive oncology care. Its usage is particularly prevalent among patients with gastric, esophageal, and head and neck cancers, where the ability to maintain oral intake is often compromised. This growing clinical demand continues to position oncology as a dominant force shaping the future of the enteral nutrition market. Asia's Nutrition Shift: APAC Takes the Lead in Enteral Nutrition Market APAC is the most dominant region for the global enteral nutrition market, accounting for around 41% of the share. In the APAC region, the demand for enteral nutrition (EN) therapies is driven by a large and diverse target patient population. This includes the growing geriatric population with chronic diseases, pediatric patients with low birth weight or malnutrition, and critically ill individuals suffering from accidental or physical injuries, all of whom contribute significantly to the rising need for EN therapies. China and India are among the leading countries in APAC with a substantial target patient base. Meanwhile, Japan also shows considerable demand for enteral nutrition due to broad healthcare access and higher spending on related services and solutions. Home enteral nutrition (HEN) delivery is gaining popularity in several APAC countries. Australia has demonstrated strong support through healthcare infrastructure and funding for HEN services. In Japan, the National Health Insurance program offers comprehensive coverage for home-based EN services. In India, both public and private health insurance policies cover portions of HEN services and products. These supportive factors are contributing to the increasing demand for enteral nutrition in home care settings across the region. Key Vendors Abbott Key Developments Key Strategies Key Opportunities Key Strengths B. Braun SE Danone Nestlé Fresenius Kabi AG Other Prominent Vendors Ajinimoto Cambrooke Global Health Products Medtrition Medica Nutrition Megalabs USA, LLC. -Victus Meiji Holdings Co., Ltd. Nutrisens Otsuka Holdings Reckitt Benckiser Group PLC Solace Nutrition Whole Enteral Market Segmentation & Forecast By Feeding Method Tube Feeding Oral Feeding By Patient Group Adults Pediatrics By Indication Oncology Gastrointestinal Disease (GI) Neurological Diseases Cardiology & Pulmonology Diseases Other Indications By End-User Hospitals Outpatient Care Settings Homecare Settings By Geography APAC China Japan India South Korea Australia North America US Canada Europe Germany UK France Spain Italy Latin America Brazil Mexico Argentina Middle East & Africa Turkey Saudi Arabia South Africa Other Related Reports that Might be of Your Business Requirement Global Parenteral Nutrition Market - Focused Insights 2024-2029 Global Senior Adult Nutrition Market - Focused Insights 2025-2030 What Key Findings Will Our Research Analysis Reveal? How big is the global enteral nutrition market? What is the growth rate of the global enteral nutrition market? Which type of enteral nutrition product will dominate the market growth? What are the factors driving the global enteral nutrition market growth? Which region dominates the global enteral nutrition market growth? Who are the major players in the global enteral nutrition market? About Focus Reports Welcome to Focus Reports, an esteemed Arizton Advisory & Intelligence subsidiary committed to delivering precise and insightful market research reports across all key geographies. Our unique selling proposition lies in our affordable pricing, accurate data, in-depth research, and presentation-ready reports. With us, expensive market research is outdated. We aim to be strategic, providing valuable data.
